Organon & Co’s filing revealed that its Director COX CARRIE SMITH acquired Company’s shares for reported $0.1 million on May 14 ’25. In the deal valued at $8.07 per share,12,469 shares were bought. As a result of this transaction, COX CARRIE SMITH now holds 12,469 shares worth roughly $88031.14.
Then, Falcione Aaron bought 5,500 shares, generating $48,235 in total proceeds. Upon buying the shares at $8.77, the Chief Human Resources Officer now owns 62,974 shares.
Before that, Weaver Kirke bought 8,045 shares. Organon & Co shares valued at $74,054 were divested by the Gen. Counsel & Corp. Secy. at a price of $9.21 per share. As a result of the transaction, Weaver Kirke now holds 52,489 shares, worth roughly $0.37 million.
Piper Sandler downgraded its Organon & Co [OGN] rating to an Underweight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who decreased its forecast for the stock in early May from “an Outperform” to “an In-line”. JP Morgan also remained covering OGN and has decreased its forecast on September 06, 2024 with a “an Underweight” recommendation from previously “Neutral” rating. Goldman revised its rating on November 03, 2023. It rated OGN as “a Neutral” which previously was an “a Buy”.
Price Performance Review of OGN
On Monday, Organon & Co [NYSE:OGN] saw its stock fall -22.93% to $7.06. Over the last five days, the stock has lost -23.59%. Organon & Co shares have fallen nearly -58.98% since the year began. Nevertheless, the stocks have fallen -52.68% over the past one year. While a 52-week high of $19.05 was reached on 02/13/25, a 52-week low of $8.01 was recorded on 10/27/25.
Levels Of Support And Resistance For OGN Stock
The 24-hour chart illustrates a support level at 6.69, which if violated will result in even more drops to 6.33. On the upside, there is a resistance level at 7.53. A further resistance level may holdings at 8.01.
How much short interest is there in Organon & Co?
A steep rise in short interest was recorded in Organon & Co stocks on 2025-10-15, dropping by -1.54 million shares to a total of 12.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 13.69 million shares. There was a decline of -12.7%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 21, 2023 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $28 price target.
